R.E. See

2.3k total citations
32 papers, 1.9k citations indexed

About

R.E. See is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Cognitive Neuroscience. According to data from OpenAlex, R.E. See has authored 32 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Cellular and Molecular Neuroscience, 14 papers in Molecular Biology and 12 papers in Cognitive Neuroscience. Recurrent topics in R.E. See's work include Neurotransmitter Receptor Influence on Behavior (27 papers), Neuroscience and Neuropharmacology Research (20 papers) and Receptor Mechanisms and Signaling (13 papers). R.E. See is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (27 papers), Neuroscience and Neuropharmacology Research (20 papers) and Receptor Mechanisms and Signaling (13 papers). R.E. See collaborates with scholars based in United States. R.E. See's co-authors include Matthew W. Feltenstein, William M. Meil, June Rogers, Shannon M. Ghee, Jay Elliott, Jacqueline F. McGinty, G Ellison, Rita A. Fuchs, Matthew C. Hearing and Jeffrey W. Grimm and has published in prestigious journals such as Brain Research, Neuroscience and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

R.E. See

32 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R.E. See United States 24 1.6k 710 632 278 202 32 1.9k
Brian A. Horger United States 14 1.7k 1.0× 719 1.0× 399 0.6× 203 0.7× 159 0.8× 22 1.9k
Paul D. Shepard United States 22 1.0k 0.6× 604 0.9× 448 0.7× 256 0.9× 265 1.3× 34 1.7k
Patricia Duffy United States 15 1.6k 1.0× 846 1.2× 362 0.6× 214 0.8× 238 1.2× 16 1.9k
Antonella Gasbarri Italy 22 1.1k 0.7× 462 0.7× 993 1.6× 212 0.8× 273 1.4× 51 2.0k
Robert Ranaldi United States 28 1.5k 0.9× 711 1.0× 545 0.9× 241 0.9× 132 0.7× 78 1.8k
Guy Sandner France 26 1.3k 0.8× 456 0.6× 930 1.5× 393 1.4× 267 1.3× 92 2.0k
Andrew M. Farrar United States 21 1.2k 0.8× 487 0.7× 661 1.0× 340 1.2× 156 0.8× 26 2.0k
PW Kalivas United States 8 2.1k 1.3× 1.2k 1.7× 418 0.7× 243 0.9× 160 0.8× 8 2.3k
Beatriz Rocha United States 23 1.9k 1.2× 1.0k 1.4× 501 0.8× 260 0.9× 207 1.0× 39 2.5k
M. Stacy Hooks United States 18 1.5k 1.0× 642 0.9× 427 0.7× 352 1.3× 383 1.9× 20 1.9k

Countries citing papers authored by R.E. See

Since Specialization
Citations

This map shows the geographic impact of R.E. See's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R.E. See with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R.E. See more than expected).

Fields of papers citing papers by R.E. See

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R.E. See. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R.E. See. The network helps show where R.E. See may publish in the future.

Co-authorship network of co-authors of R.E. See

This figure shows the co-authorship network connecting the top 25 collaborators of R.E. See. A scholar is included among the top collaborators of R.E. See based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R.E. See. R.E. See is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Feltenstein, Matthew W. & R.E. See. (2013). Systems Level Neuroplasticity in Drug Addiction. Cold Spring Harbor Perspectives in Medicine. 3(5). a011916–a011916. 33 indexed citations
2.
3.
Feltenstein, Matthew W. & R.E. See. (2008). The neurocircuitry of addiction: an overview. British Journal of Pharmacology. 154(2). 261–274. 297 indexed citations
4.
Rogers, June, et al.. (2008). Extended methamphetamine self-administration enhances reinstatement of drug seeking and impairs novel object recognition in rats. Psychopharmacology. 199(4). 615–624. 106 indexed citations
6.
Rogers, June, Shannon M. Ghee, & R.E. See. (2007). The neural circuitry underlying reinstatement of heroin-seeking behavior in an animal model of relapse. Neuroscience. 151(2). 579–588. 167 indexed citations
7.
See, R.E., Jay Elliott, & Matthew W. Feltenstein. (2007). The role of dorsal vs ventral striatal pathways in cocaine-seeking behavior after prolonged abstinence in rats. Psychopharmacology. 194(3). 321–331. 130 indexed citations
8.
Feltenstein, Matthew W. & R.E. See. (2006). Potentiation of cue-induced reinstatement of cocaine-seeking in rats by the anxiogenic drug yohimbine. Behavioural Brain Research. 174(1). 1–8. 128 indexed citations
9.
Hadden, M. Kyle, et al.. (2005). In vivo behavioral effects of stable, receptor-selective neurotensin[8?13] analogues that cross the blood?brain barrier. Neuropharmacology. 48(3). 417–425. 23 indexed citations
11.
See, R.E., Joselyn McLaughlin, & Rita A. Fuchs. (2003). Muscarinic receptor antagonism in the basolateral amygdala blocks acquisition of cocaine-stimulus association in a model of relapse to cocaine-seeking behavior in rats. Neuroscience. 117(2). 477–483. 65 indexed citations
12.
Kruzich, Paul J., et al.. (2001). Conditioned reinstatement of drug-seeking behavior with a discrete compound stimulus classically conditioned with intravenous cocaine.. Behavioral Neuroscience. 115(5). 1086–1092. 37 indexed citations
13.
Kruzich, Paul J., Jeffrey W. Grimm, Nathan R. Rustay, Craig D. Parks, & R.E. See. (1999). Predicting relapse to cocaine-seeking behavior: A multiple regression approach. Behavioural Pharmacology. 10(5). 513–521. 26 indexed citations
15.
See, R.E., et al.. (1995). Chronic haloperidol-induced changes in regional dopamine release and metabolism and neurotensin content in rats. Brain Research. 704(2). 202–209. 24 indexed citations
16.
Meil, William M. & R.E. See. (1994). Single preexposure to fluphenazine produces persisting behavioral sensitization accompanied by tolerance to fluphenazine-induced striatal dopamine overflow in rats. Pharmacology Biochemistry and Behavior. 48(3). 605–612. 7 indexed citations
17.
See, R.E.. (1994). Differential effects of 3-PPP enantiomers on extracellular dopamine concentration in the caudate-putamen and nucleus accumbens of rats. Naunyn-Schmiedeberg s Archives of Pharmacology. 350(6). 605–10. 4 indexed citations
18.
See, R.E., et al.. (1992). Chronic neuroleptic administration decreases extracellular GABA in the nucleus accumbens but not in the caudate-putamen of rats. Brain Research. 588(1). 177–180. 14 indexed citations
19.
See, R.E., Arthur W. Toga, & G Ellison. (1990). Autoradiographic analysis of regional alterations in brain receptors following chronic administration and withdrawal of typical and atypical neuroleptics in rats. Journal of Neural Transmission. 82(2). 93–109. 50 indexed citations
20.
See, R.E., et al.. (1988). Characteristics of oral movements in rats during and after chronic haloperidol and fluphenazine administration. Psychopharmacology. 94(3). 421–7. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026